Apollomics Inc Ordinary Shares - Class A APLM 深 滬
已收盤 10-24 16:00:00 美东时间
23.00
-5.213
-18.48%
華盛通- 最 高26.96
- 今 開26.96
- 成交量 1.45万股
- 最 低 22.64
- 昨 收 28.2131
- 總市值 2537.59万
- 52周最高 42.12
- 市盈率 靜 --
- 換手率 1.32%
- 52周最低 3.659
- 委 比 75.00%
- 總股本 110.33万
- 歷史最高 4900.00
- 量 比 0.26
- 振 幅 15.31%
- 歷史最低 3.659
- 每 手 1
- 風險率 5.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多鞍石生物闯关科创板 会重走冠科美博的纳斯达克之路吗？
IPO参考 “天地板”行情剧本在纳斯达克上演升级版本。 2025年10月15日，冠科美博（APLM.O）复牌首日以18.25美元/股小幅低开，盘中一度...
10-23 09:40
Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation
<p>Foster City, Calif., Oct. 15, 2025 - Apollomics Inc. (Nasdaq: APLM), a California-based clinical-stage biopharmaceutical company focused on developing oncology therapies, has announced that Nasdaq has canceled its scheduled hearing on the company's appeal of a delisting notification. Nasdaq determined that Apollomics is in compliance with its continued listing requirements, ensuring the company's securities remain listed and trading on The Nas...
10-15 18:36
Nasdaq To Resume Trading In Apollomics Shares And Warrants On October 15, 2025
The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading will resume in Apollomics Inc. Class A ordinary shares (NASDAQ:APLM) and warrants (NASDAQ:APLMW) at 9:00 a.m. and 9:05 a.m. Eastern Time, respectively,
10-15 04:08
Nasdaq Resumes Trading in Apollomics Inc.
Trading in Apollomics Inc. Class A ordinary shares (APLM) and warrants (APLMW) will resume on October 15, 2025, at 9:00 a.m. ET and 9:05 a.m. ET, respectively, after being halted on September 17, 2025, at 2:37:17 p.m. ET.
10-14 20:05
Apollomics, Inc. Company Operational Continuity Update
Apollomics Inc., a clinical-stage biotechnology company, aims to transform cancer treatment through innovative therapies. With nine product candidates, including six in clinical development, the company focuses on challenging cancers like lung and brain cancer. APL-101 (vebreltinib), a promising targeted therapy, is in a global Phase 2 trial after positive results from trials involving over 280 patients. Despite earlier plans to discontinue trial...
10-14 01:22
Nasdaq Halts Apollomics Inc., Ltd.
The Nasdaq Stock Market announced on September 17, 2025 that trading in Apollomics Inc., Ltd. was halted at 14:37:17 Eastern Time for additional information requested from the company. The last sale price of the company’s ordinary shares was $18.4331 (Nasdaq: APLM), and warrants was $0.0191 (Nasdaq: APLMW). Trading will remain halted until Apollomics Inc. fully satisfies Nasdaq’s request.
09-17 21:48
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Biodesix (NASDAQ:BDSX) shares increased by 21.6% to $0.52 during Wedne...
09-04 05:06
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Ironwood Pharmaceuticals (NASDAQ:IRWD) stock rose 15.2% to $0.71 durin...
06-14 05:05
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Biodesix (NASDAQ:BDSX) shares increased by 72.6% to $0.47 during Wedne...
05-22 01:06
Apollomics shares are trading lower. The company reported FY24 financial results.
Apollomics shares are trading lower. The company reported FY24 financial result...
04-05 02:48
